PTC Therapeutics, Inc.

ISIN US69366J2006

 | 

WKN A1W0MW

Market cap (in EUR)
4,552 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 4,552 m
EPS, EUR 6.86
P/B ratio -
P/E ratio 8.1
Dividend yield 0.00%

Winst- en verliesrekening (2025)

Revenue, EUR 1,534 m
Net income, EUR 605 m
Profit margin 39.44%

In welke ETF zit PTC Therapeutics, Inc.?

Er zijn 5 ETF's die PTC Therapeutics, Inc. bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van PTC Therapeutics, Inc. is de iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0,46%
Aandelen
Verenigde Staten
Gezondheidszorg
Biotech
47
iShares S&P SmallCap 600 UCITS ETF 0,39%
Aandelen
Verenigde Staten
Small Cap
2.254
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0,01%
Aandelen
Wereld
Sociaal/Milieu
480
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0,01%
Aandelen
Noord-Amerika
Sociaal/Milieu
24
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0,08%
Aandelen
Verenigde Staten
Small Cap
187
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.